Banerjee, Susana N.
Lord, Christopher J.
Article History
First Online: 12 February 2020
Competing interests
: S.B. has received honoraria as an advisory board member and/or giving lectures for AstraZeneca, Clovis, Genmabs, Merck Serono, Pharmamar, Roche, Seattle Genetics and Tesaro/GSK. C.J.L. has received research funding from Artios, AstraZeneca and Merck KGaA; has received honoraria as a consultant or senior advisory board for Artios, AstraZeneca, Gerson Lehrman Group, Merck KGaA, Ono Pharma, Sun Pharma, Syncona, Tango, Third Rock and Vertex; owns stock in Ovibio and Tango; and is a named inventor on patents describing the use of DNA repair inhibitors and stands to gain from the development as part of the ICR Rewards to Inventors scheme.